학술논문
Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial
Document Type
Article
Author
Gonzalez-Lugo, J.D.; Bhagat, P.; Fehn, K.; Remy, C.; Pradhan, K.; Mantzaris, I.; Sica, R.A.; Shah, N.; Goldfinger, M.; Kornblum, N.; Gritsman, K.; Braunschweig, I.; Steidl, U.; Will, B.; Shastri, A.; Verma, A.; Kambhampati, S.; Yacoub, A.; Donnellan, W.B.; Berdeja, J.; Jasra, S.; Kazemi, M.; Kim, M.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 1 January 2023, 29(1):60-66)
Subject
Language
English
ISSN
15573265
10780432
10780432